QUANTUM BIOPHARMA LTD (QNTM) Stock Income Statement
NASDAQ:QNTM - Nasdaq - CA74764Y2050 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 187.10K | 66.50K | |||
| Cost Of Goods | N/A | N/A | N/A | 1.44M | N/A | |||
| Gross Profit | N/A | N/A | N/A | -1.25M | N/A | |||
| Operating Expenses | 18.67M | 33.74M | 29.84M | 24.69M | 24.62M | |||
| Research and Development | 7.22M | 6.33M | 7.83M | N/A | N/A | |||
| Selling, General, and Administrative Expenses | 10.95M | 23.37M | 18.11M | 22.40M | 18.86M | |||
| Operating Income | -18.67M | -33.74M | -29.84M | -25.95M | -24.55M | |||
| Interest Income/Expense | -10.68M | -195.60K | 2.24M | -11.32M | 7.54M | |||
| Other Income/Expense | N/A | 1.30K | 3.70K | 91.30K | N/A | |||
| Non Recurring Items | -665.60K | 0.00 | -847.70K | -674.00K | N/A | |||
| Income Before Taxes | -27.98M | -33.94M | -28.45M | -37.85M | -17.01M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -26.59M | -35.29M | -31.80M | -37.85M | -17.01M | |||
| EBITDA | -18.17M | -29.70M | -25.94M | -23.59M | -24.41M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -13.30 | -65.65 | -171.66 | -348.74 | -2.88 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | -670.55% | N/A | |||
| Profit Margin | N/A | N/A | N/A | -20228.22% | -25579.55% | |||
| Operating Profit Margin | N/A | N/A | N/A | -13868.09% | -36915.64% | |||
All data in USD